CPIX vs V · rev $10.4M vs P/E 33, rev $40.00B
Cumberland Pharmaceuticals Inc (CPIX) versus Visa Inc. Class A (V) — a side-by-side from cached financials, not a winner call.
Cumberland Pharmaceuticals Inc (CPIX) is a drug manufacturers - specialty & generic company listed on US.
Visa Inc. Class A (V) is a credit services company listed on US. It is led by Ryan McInerney.
Latest reported CPIX revenue for 2024-12-31 was $10.4M. Net income was -$1.9M. Revenue was up 14.9% from 2024-09-30 to 2024-12-31. CPIX currently screens at market cap $86.9M.
Latest reported V revenue for 2025-09-30 was $40.00B. Net income was $20.06B. V currently screens at market cap $659.78B and trailing P/E 33.5.
CPIX currently screens at market cap $86.9M. V currently screens at market cap $659.78B and trailing P/E 33.5.
Not investment advice. Open the CPIX and V stock pages for the full models.
Not investment advice.